Stay updated on Neo-Kan: Adagrasib +/- Nivolumab Clinical Trial
Sign up to get notified when there's something new on the Neo-Kan: Adagrasib +/- Nivolumab Clinical Trial page.

Latest updates to the Neo-Kan: Adagrasib +/- Nivolumab Clinical Trial page
- Check3 days agoChange DetectedThe page’s footer/site revision was updated from v3.5.0 to v3.5.3, reflecting a clinicaltrials.gov software/version update rather than changes to the study record itself.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedRevision v3.5.0 was added to the Record History and revision v3.4.3 was removed.SummaryDifference0.1%

- Check46 days agoChange DetectedNew revision entry v3.4.3 added to the Record History and the v3.4.2 entry removed.SummaryDifference0.1%

- Check74 days agoChange DetectedAdded Revision: v3.4.2 and removed Revision: v3.4.1 from the history, reflecting a site version update.SummaryDifference0.1%

- Check82 days agoChange DetectedThe revision history shows v3.4.1 added and v3.4.0 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check89 days agoChange DetectedThe update adds UI elements to the Record History page, including a Show glossary option and color-coded (green for additions, red for deletions) highlights and legends (No FEAR Act Data, Revision: v3.4.0); to avoid alerts for small changes, set an alert condition by clicking below. The changes do not modify the underlying study data or core page content.SummaryDifference1%

Stay in the know with updates to Neo-Kan: Adagrasib +/- Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neo-Kan: Adagrasib +/- Nivolumab Clinical Trial page.